RxDoctor Payments Data

Zackary Burrow, MD

Adult Reconstructive Orthopaedic Surgery · Tulsa, OKNPI 1902339732

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (41.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Pylant Medical at 41.9% of the total. Reporting peaked in 2019 at $5,833 and has fallen 95.9% since, to $242 in 2025.

$16,891in general payments, 2019–2025

Across 100 payments — averaging $168.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pylant Medical$7K
  • Zimmer Biomet$4K
  • Ortho Development Corporation$2K
  • Stryker$2K
  • Axogen$591
  • Total Joint Orthopedics, Inc.$267
  • plus $601 from 10 others

What the payments were for

  • Travel & lodging$4,83229%
  • Food & beverage$5,00530%
  • Education$7,05442%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few adult reconstructive orthopaedic surgery providers in Oklahomato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$187,358
Medicare patients
295
Services billed
2,775

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib276$5,815
Oxycodone Hcl162$1,047
Ondansetron OdtOndansetron101$1,000
Meloxicam119$527
Cefadroxil72$494
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$276
Diclofenac Sodium13$158
Tramadol Hcl29$124
Gabapentin28$85
Cyclobenzaprine Hcl14$72
Clindamycin Hcl11$27
Amoxicillin18$17

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →